Hi David,Welcome to the board. I suspect there are still a few of us lurking here, but there hasn't been much to talk about; hence the paucity of postings. The company conutinues to execute as expected, while the economy stays in the doldrums. So it remains a "wait and see" situation for most of the market. FWIW, I discovered LCI through a Foolish 8 screen. Small caps often lead during a recovery, or so I've been told :) Thus I'm looking to allocate some funds to the small cap sector at this point in history. I like this company's fundamentals and their management. Faced with an aging population and skyrocketing health care costs in the US, I think generics are a good industry going forward. A few posts back, I outlined why I thought $15.23 was a good purchase price for Lannett, using pretty conservative assumptions. I haven't changed my views much since then. I watch LCI very closely for the unexpected -- problems with the FDA or botched product introductions, or the hint of options abuse or other greediness by management would turn me off. So far so good.So what is it that you like about this company? Or don't like?
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat